Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Exposure determinants of cadmium in European mothers and their children

  • Berglund, Marika
  • Larsson, Kristin
  • Grandér, Margaretha
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Schwedler, Gerda
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Angerer, Jürgen
  • Koch, Holger M
  • Schindler, Birgit K
  • Schoeters, Greet
  • Smolders, Roel
  • Exley, Karen
  • Sepai, Ovnair
  • Blumen, Luies
  • Horvat, Milena
  • Knudsen, Lisbeth E
  • Mørck, Thit A
  • Joas, Anke
  • Joas, Reinhard
  • Biot, Pierre
  • Aerts, Dominique
  • De Cremer, Koen
  • Van Overmeire, Ilse
  • Katsonouri, Andromachi
  • Hadjipanayis, Adamos
  • Černá, Milena
  • Krskova, Andrea
  • Nielsen, Jeanette K S
  • Jensen, Janne Fangel
  • Rudnai, Peter
  • Középesy, Szilvia
  • Griffin, Chris
  • Nesbitt, Ian
  • Gutleb, Arno C
  • Fischer, Marc E
  • Ligocka, Danuta
  • Jakubowski, Marek
  • Reis, M Fátima
  • Namorado, Sónia
  • Lupsa, Ioana-Rodica
  • Gurzau, Anca Elena
  • Halzlova, Katarina
  • Jajcaj, Michal
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Lopez-Herranz, Ana
  • Cañas Portilla, Ana Isabel
  • Lehmann, Andrea
  • Crettaz, Pierre
  • Den Hond, Elly
  • Govarts, Eva
The metal cadmium (Cd) is a widespread environmental pollutant with documented adverse effects on the kidneys and bones from long-term environmental exposure, but with insufficiently elucidated public health consequences such as risk of cardiovascular disease, hormone-related cancer in adults and developmental effects in children. This study is the first pan-European human biomonitoring project that succeeded in performing harmonized measurements of Cd in urine in a comparable way in mother-child couples from 16 European countries. The aim of the study was to evaluate the overall Cd exposure and significant determinants of Cd exposure. A study population of 1632 women (24-52 years of age), and 1689 children (5-12 years of age), from 32 rural and urban areas, was examined within a core period of 6 months in 2011-2012. Women were stratified as smokers and non-smokers. As expected, smoking mothers had higher geometric mean (gm) urinary cadmium (UCd; 0.24 µg/g crea; n=360) than non-smoking mothers (gm 0.18 µg/g crea; n=1272; p<0.0001), and children had lower UCd (gm 0.065 µg/g crea; n=1689) than their mothers at the country level. Non-smoking women exposed to environmental tobacco smoke (ETS) at home had 14% (95% CI 1-28%) higher UCd than those who were not exposed to ETS at home (p=0.04). No influence of ETS at home or other places on UCd levels was detected in children. Smoking women with primary education as the highest educational level of the household had 48% (95% CI 18-86%) higher UCd than those with tertiary education (p=0.0008). The same observation was seen in non-smoking women and in children; however they were not statistically significant. In children, living in a rural area was associated with 7% (95% CI 1-13%) higher UCd (p=0.03) compared to living in an urban area. Children, 9-12 years had 7% (95% CI 1-13%) higher UCd (p=0.04) than children 5-8 years. About 1% of the mothers, and 0.06% of the children, exceeded the tolerable weekly intake (TWI) appointed by EFSA, corresponding to 1.0 µg Cd/g crea in urine. Poland had the highest UCd in comparison between the 16 countries, while Denmark had the lowest. Whether the differences between countries are related to differences in the degree of environmental Cd contamination or to differences in lifestyle, socioeconomic status or dietary patterns is not clear.
Repisalud
Publication Artículo científico (JournalArticle)

The European COPHES/DEMOCOPHES project: towards transnational comparability and reliability of human biomonitoring results

  • Schindler, Birgit Karin
  • Esteban-Lopez, Marta
  • Koch, Holger M
  • Castaño, Argelia
  • Koslitz, Stephan
  • Cañas, Ana
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Schwedler, Gerda
  • Schoeters, Greet
  • Hond, Elly Den
  • Sepai, Ovnair
  • Exley, Karen
  • Bloemen, Louis
  • Horvat, Milena
  • Knudsen, Lisbeth E
  • Joas, Anke
  • Joas, Reinhard
  • Biot, Pierre
  • Aerts, Dominique
  • Lopez-Herranz, Ana
  • Huetos, Olga
  • Katsonouri, Andromachi
  • Maurer-Chronakis, Katja
  • Kasparova, Lucie
  • Vrbík, Karel
  • Rudnai, Peter
  • Naray, Miklos
  • Guignard, Cedric
  • Fischer, Marc E
  • Ligocka, Danuta
  • Janasik, Beata
  • Reis, M Fátima
  • Namorado, Sónia
  • Pop, Cristian
  • Dumitrascu, Irina
  • Halzlova, Katarina
  • Fabianova, Eleonora
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Berglund, Marika
  • Jönsson, Bo
  • Lehmann, Andrea
  • Crettaz, Pierre
  • Frederiksen, Hanne
  • Nielsen, Flemming
  • McGrath, Helena
  • Nesbitt, Ian
  • De Cremer, Koen
  • Vanermen, Guido
  • Koppen, Gudrun
  • Wilhelm, Michael
  • Becker, Kerstin
  • Angerer, Jürgen
COPHES/DEMOCOPHES has its origins in the European Environment and Health Action Plan of 2004 to "develop a coherent approach on human biomonitoring (HBM) in Europe". Within this twin-project it was targeted to collect specimens from 120 mother-child-pairs in each of the 17 participating European countries. These specimens were investigated for six biomarkers (mercury in hair; creatinine, cotinine, cadmium, phthalate metabolites and bisphenol A in urine). The results for mercury in hair are described in a separate paper. Each participating member state was requested to contract laboratories, for capacity building reasons ideally within its borders, carrying out the chemical analyses. To ensure comparability of analytical data a Quality Assurance Unit (QAU) was established which provided the participating laboratories with standard operating procedures (SOP) and with control material. This material was specially prepared from native, non-spiked, pooled urine samples and was tested for homogeneity and stability. Four external quality assessment exercises were carried out. Highly esteemed laboratories from all over the world served as reference laboratories. Web conferences after each external quality assessment exercise functioned as a new and effective tool to improve analytical performance, to build capacity and to educate less experienced laboratories. Of the 38 laboratories participating in the quality assurance exercises 14 laboratories qualified for cadmium, 14 for creatinine, 9 for cotinine, 7 for phthalate metabolites and 5 for bisphenol A in urine. In the last of the four external quality assessment exercises the laboratories that qualified for DEMOCOPHES performed the determinations in urine with relative standard deviations (low/high concentration) of 18.0/2.1% for cotinine, 14.8/5.1% for cadmium, 4.7/3.4% for creatinine. Relative standard deviations for the newly emerging biomarkers were higher, with values between 13.5 and 20.5% for bisphenol A and between 18.9 and 45.3% for the phthalate metabolites. Plausibility control of the HBM results of all participating countries disclosed analytical shortcomings in the determination of Cd when using certain ICP/MS methods. Results were corrected by reanalyzes. The COPHES/DEMOCOPHES project for the first time succeeded in performing a harmonized pan-European HBM project. All data raised have to be regarded as utmost reliable according to the highest international state of the art, since highly renowned laboratories functioned as reference laboratories. The procedure described here, that has shown its success, can be used as a blueprint for future transnational, multicentre HBM projects.